The VP-RT + VP-Cag blend combines a triple-agonist peptide (targeting GLP-1, GIP, and glucagon receptors) with a long-acting amylin analog, creating one of the most pharmacologically comprehensive research blends available. This combination enables investigation of four distinct receptor systems simultaneously.
Four-Receptor Research Tool
By combining VP-RT’s GLP-1/GIP/glucagon activation with VP-Cag’s amylin receptor engagement, researchers can study the integrated effects of the four major metabolic signaling pathways. This is particularly valuable for systems-level metabolic research where understanding pathway crosstalk is essential.
Research Design Applications
This blend is suited for multi-receptor binding assays, comparative selectivity profiling against the individual components, and analytical characterization of blend ratios. Researchers can compare outcomes against individual components and dual-agonist blends to parse the contribution of each receptor system.
Formulation and Quality
Available in 10mg total concentration from Vault Peptides. Tested as a complete formulation with batch-specific CoA documentation verifying both component identity and blend stability.
Disclaimer: All products referenced in this article are intended for laboratory and research use only. They are not intended for human consumption. By purchasing from Vault Peptides, you acknowledge these products are for research purposes only and agree to comply with all applicable laws and regulations. Vault Peptides does not make any claims regarding efficacy or safety for non-research applications.
Vault Peptides. Research Use Only. Vault-Sealed.
Independent-lab certificates of analysis are published where available. USA-based. Orders ship on business days. Tracking is provided as soon as the label is generated.
Continue Your Research
- Related Product: VP-Rt 30mg
- VP-RT Research
- VP-CAG & VP-Sema Blend
RESEARCH DOCUMENTATION
Get new lot reports and research-documentation updates
Subscribe for analytical-report guides and updates to our research documentation.
Confirm your email to subscribe. Unsubscribe at any time. Privacy policy.
